These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32981505)

  • 21. Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins.
    Buonomo T; Carraresi L; Rossini M; Martinelli R
    J Transl Med; 2011 Jan; 9():2. PubMed ID: 21205295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.
    Stiasny A; Kuhn C; Mayr D; Alexiou C; Janko C; Wiest I; Jeschke U; Kost B
    Anticancer Res; 2016 Jun; 36(6):3195-8. PubMed ID: 27272848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines.
    Bourgo RJ; Braden WA; Wells SI; Knudsen ES
    Mol Carcinog; 2009 Jan; 48(1):45-55. PubMed ID: 18506774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
    von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
    J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation.
    Weijzen S; Zlobin A; Braid M; Miele L; Kast WM
    J Cell Physiol; 2003 Mar; 194(3):356-62. PubMed ID: 12548555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV: Molecular pathways and targets.
    Gupta S; Kumar P; Das BC
    Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis.
    Mellone M; Rinaldi C; Massimi I; Petroni M; Veschi V; Talora C; Truffa S; Stabile H; Frati L; Screpanti I; Gulino A; Giannini G
    Neoplasia; 2008 Aug; 10(8):773-81. PubMed ID: 18670638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins.
    Duensing S; Münger K
    Int J Cancer; 2004 Mar; 109(2):157-62. PubMed ID: 14750163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
    Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
    PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Autophagy Process in Cervical Carcinogenesis: Role of Non-Coding-RNAs, Molecular Mechanisms, and Therapeutic Targets.
    Lagunas-Martínez A; Madrid-Marina V; Gómez-Cerón C; Deas J; Peralta-Zaragoza O
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].
    Ardiç N; Oztürk O; Ergünay K; Sezer O
    Mikrobiyol Bul; 2009 Jul; 43(3):463-9. PubMed ID: 19795622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women.
    Rodrigues LC; Speck NM; Focchi GR; Schimidt MA; Marques RM; Ribalta JC
    Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness.
    Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
    J Pathol; 2018 Feb; 244(2):151-163. PubMed ID: 28944962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Centrosomes, genomic instability, and cervical carcinogenesis.
    Duensing S; Münger K
    Crit Rev Eukaryot Gene Expr; 2003; 13(1):9-23. PubMed ID: 12839094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
    Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
    Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current advances in the mechanic studies of human papillomavirus-induced oncogenesis].
    Zhou XB; Xu NZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):673-7. PubMed ID: 18051727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.